Imunon Statistics

Total Valuation

Imunon has a market cap or net worth of $10.72 million. The enterprise value is -$3.36 million.

Market Cap	10.72M
Enterprise Value	-3.36M

Important Dates

The next estimated earnings date is Thursday, May 9, 2024, before market open.

Earnings Date	May 9, 2024
Ex-Dividend Date	n/a

Share Statistics

Imunon has 9.40 million shares outstanding. The number of shares has increased by 26.63% in one year.

Shares Outstanding	9.40M
Shares Change (YoY)	+26.63%
Shares Change (QoQ)	+0.28%
Owned by Insiders (%)	1.15%
Owned by Institutions (%)	4.47%
Float	9.37M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.80
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.47, with a Debt / Equity ratio of 0.12.

Current Ratio	2.47
Quick Ratio	n/a
Debt / Equity	0.12
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-104.52

Financial Efficiency

Return on equity (ROE) is -98.00% and return on invested capital (ROIC) is -140.09%.

Return on Equity (ROE)	-98.00%
Return on Assets (ROA)	-66.50%
Return on Capital (ROIC)	-140.09%
Revenue Per Employee	n/a
Profits Per Employee	-$591,363
Employee Count	33
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-1.28M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.72% in the last 52 weeks. The beta is 2.01, so Imunon's price volatility has been higher than the market average.

Beta (1Y)	2.01
52-Week Price Change	-1.72%
50-Day Moving Average	0.99
200-Day Moving Average	0.99
Relative Strength Index (RSI)	45.76
Average Volume (30 Days)	221,448

Short Selling Information

The latest short interest is 443,265, so 4.72% of the outstanding shares have been sold short.

Short Interest	443,265
Short Previous Month	449,129
Short % of Shares Out	4.72%
Short % of Float	4.73%
Short Ratio (days to cover)	1.14

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-21.03M
Pretax Income	-20.80M
Net Income	-19.51M
EBITDA	-19.88M
EBIT	-20.60M
Earnings Per Share (EPS)	-$2.16

Full Income Statement

Balance Sheet

The company has $15.70 million in cash and $1.62 million in debt, giving a net cash position of $14.07 million or $1.50 per share.

Cash & Cash Equivalents	15.70M
Total Debt	1.62M
Net Cash	14.07M
Net Cash Per Share	$1.50
Equity / Book Value	13.39M
Book Value Per Share	1.42
Working Capital	10.85M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$19.02 million and capital expenditures -$451,759, giving a free cash flow of -$19.47 million.

Operating Cash Flow	-19.02M
Capital Expenditures	-451,759
Free Cash Flow	-19.47M
FCF Per Share	-$2.15

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Imunon does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-26.63%
Shareholder Yield	-26.63%
Earnings Yield	-182.11%
FCF Yield	-181.73%

Analyst Forecast

The average price target for Imunon is $13.00, which is 1,040.35% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.00
Price Target Difference	1,040.35%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on March 1, 2022. It was a reverse split with a ratio of 1:15.

Last Split Date	Mar 1, 2022
Split Type	Reverse
Split Ratio	1:15

Scores

Altman Z-Score	n/a
Piotroski F-Score	2